Media Relations

How PR Pros Can Make Themselves Media Friendly

July 20th, 2020 by

It’s like a swimmer who hates water, but some PR pros don’t relish dealing with members of the media. Worse, some lack news sense or have never spoken with a journalist. Fortunately, it’s not too difficult to become a media-friendly PR pro. Here are a number of tips from veteran PR pro and former journalist Arthur Solomon that can help you become media friendly.

Unmasking The Truth Behind Retailers’ Face-Covering Rule

July 17th, 2020 by

A well-known PR adage is, ‘If you don’t tell your story, someone else will.’ A bevy of major retailers has paraphrased that aphorism to fit the moment: ‘If the government doesn’t protect our employees and customers against coronavirus, we will.’ By requiring masks, these iconic brands have become healthcare policy wonks.

Dr. Fauci

Why the White House Smear Campaign Will Not Topple Fauci

July 13th, 2020 by

The White House has turned up the gas on a campaign to discredit Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. The Washington Post published an article July 11 outlining the various ways the White House has silenced Fauci over the past several weeks. The report aired a statement from the Trump administration claiming “several White House officials are concerned about the number of times Dr. Fauci has been wrong on things,” which, according to the Post, “included a lengthy list of the scientist’s comments from early in the outbreak.”

Matt Newey on mountain

How an Amateur Learned to Pitch Like a PR Pro During the Pandemic

July 10th, 2020 by

Most PR pros learn about media relations in school or on the job. Matt Newey, a photographer and ski nut, absorbed some of the basics through trial and error. He pitched his personal story of contracting COVID-19 to hundreds of reporters. It worked.

robinhood landing page

Robinhood Watches and Waits as Mixed Press Trickles In

July 9th, 2020 by

The investment management and stock trading app Robinhood has come under fire in recent months for its allure to young and inexperienced investors. On July 8, a New York Times report took a look at those who have played the stocks and lost big on the app, delving into common complaints from Robinhood users including gamification and technical glitches. How should its communication team respond?

Influencers Pivot to Public Sector and Education During Pandemic

July 9th, 2020 by

The pandemic has caused more than a few sectors to pivot. Why not influencers? With travel and leisure destinations largely off the radar, influencers increasingly are working with the public sector, education organizations and social causes. The goal in most cases is to promote awareness of health and other messages.

Ask a Reporter: Ben Fischer, Staff Writer, Sports Business Journal

July 7th, 2020 by

Recently, our team at PRNEWS decided to revive a series for our readers: “Ask a Reporter.” With logistical changes in the workforce, as well as a news cycle that just won’t quit, PR and media need to work more harmoniously than ever to get the public the information it needs. During “Ask a Reporter” we will interview a fellow journalist, finding out what works best for them when it comes to media relations.

newspapers lined up

Navigating Media Relations in the New Normal is Similar to Pre-Virus Times

July 1st, 2020 by

Developing relationships with content creators remains a top priority for media relations pros. The pandemic has forced adjustments in this area, but the fundamentals of media relations remain stable.

business people collaborating

Value and PR Must be Linked to Maintain Business Strength During COVID-19

July 1st, 2020 by

Faced with a long-term crisis, a media landscape that transformed priorities seemingly overnight and budgets of many businesses frozen, PR pros need to adapt. Here are some strategies to use.

Gilead Sciences Outlines Pricing Process for Treatment in Statement

June 29th, 2020 by

While the announcement of an effective drug treatment available worldwide for those suffering from the cryptic virus should be something to celebrate, delving into an explanation about pricing for a possibly life-saving drug may cause some reader’s stomachs to churn. Gilead’s statement attempts to strike a delicate balance, focusing on the importance of the treatment while justifying its value.